Hindered Phenol Compounds Inhibit RPE Degeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is no established treatment for geographic atrophy (GA), a late stage of dry age-related macular degeneration (AMD) that causes severe and irreversible vision loss, and the mechanisms underlying its pathogenesis remain unknown.
Innovation Solution
Development of compounds with a hindered phenol group, such as analogs of trolox or BHT, which are administered to inhibit retinal pigment epithelium (RPE) degeneration associated with AMD, offering potent protective activity against RPE death and degeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If no therapy is approved for the treatment of GA, then the unmet need in ophthalmology remains, but severe and irreversible vision loss occurs
Solution Approach 1:
The patent introduces hindered phenol compounds as intermediary substances that mediate between oxidative stress/inflammation and RPE cell damage. These compounds act as protective intermediaries that neutralize harmful reactive oxygen species and inflammatory mediators, thereby preventing direct damage to RPE cells and preserving vision function in GA/AMD conditions
Solution Approach 2:
The patent converts harmful oxidative stress and inflammation into beneficial protective effects by using hindered phenol compounds that specifically target and neutralize these harmful factors. The compounds transform the pathological environment of oxidative damage into a protected state where RPE cells are shielded from further injury, effectively converting the harmful context into a therapeutic opportunity
2Reliability
If compounds with hindered phenol group are administered, then RPE protective activity is enhanced, but compound structure complexity increases
Solution Approach 1:
The patent systematically modifies molecular parameters of phenol compounds by introducing hindered groups at specific positions (ortho positions) of the phenol ring. This parameter change - adding steric hindrance through alkyl or substituted alkyl groups - fundamentally alters the compound's protective activity, making it at least 10-100% more potent than parental compounds while maintaining a relatively simple core phenol structure
Solution Approach 2:
The patent creates composite molecular structures by combining the phenol core with hindered alkyl substituents. This composite approach - merging the reactive phenol group with protective hindered groups - produces compounds that exhibit synergistic effects where the phenol provides antioxidant activity and the hindered groups provide steric protection and enhanced stability, resulting in superior RPE protective activity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compounds effectively inhibit RPE degeneration and death, providing a potential treatment for AMD and GA by suppressing oxidative stress and inflammation, as demonstrated by their ability to reduce cell death and maintain lysosomal integrity in RPE cells.
Implementation Method 1
capable of inhibiting RPE degeneration or GA associated with AMD... suppressing oxidative stress and inflammation
Implementation Method 2
suppressing oxidative stress and inflammation... as demonstrated by their ability to reduce cell death and maintain lysosomal integrity in RPE cells
Data Source
AI summary
There are provided inter alia compounds capable of inhibiting retinal pigment epithelium (RPE) degeneration or geography atrophy (GA) associated with age-related macular degeneration (AMD), and methods of using the same.